Katrine Kold Sørensen

8PUBLICATIONS
11CO-AUTHORS
Liquid biopsiesMolecular targetsPredictive and prognostic markersInfant and child healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 02, 2026
Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

|Feb 25, 2026
Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes.

Kathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini

|Oct 07, 2025
Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes.

Kathrine Kold Sørensen, Puriya Daniel Würtz Yazdanfard, Bochra Zareini

|Jul 24, 2025
Heavy prenatal alcohol exposure and healthcare use during childhood and adolescence: a Danish nationwide cohort study 1997-2022.

Julie Marie Winckler, Kathrine Kold Sørensen, Katrine Strandberg-Larsen

|Oct 04, 2024
Comparing Glucagon-like peptide-1 receptor agonists versus metformin in drug-naive patients: A nationwide cohort study.

Kathrine Kold Sørensen, Thomas Alexander Gerds, Lars Køber

|May 16, 2024
Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study.

Bochra Zareini, Katrine Kold Sørensen, Ulrik Pedersen-Bjergaard

Pageof 2

Frequent Collaborators

3 joint publications

Mikkel Porsborg Andersen

2 joint publications

Bochra Zareini

2 joint publications

Ulrik Pedersen-Bjergaard

1 joint publications

Julie Marie Winckler